Plasminogen activation in venous leg ulcers

British Journal of Dermatology

Volumn 143, Issue 5, 2000, Pages 930-936

  Herouy, Yared ^a   Trefzer, D ^a   Hellstern, M O ^a   Stark, G B ^a   Vanscheidt, W ^a   Schopf E ^a   Norgauer, J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Fibrinolytic factors; Matrix metalloproteinases; Venous ulceration

Indexed keywords

FIBRIN; GELATINASE A; PLASMINOGEN; UROKINASE; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; IMMUNOHISTOCHEMISTRY; LEG ULCER; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CAPILLARIES; FEMALE; FIBRINOLYSIS; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATORS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; URINARY PLASMINOGEN ACTIVATOR; VARICOSE ULCER;

EID: 0033748109     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03825.x     Document Type: Article

References (24)

1. The cause of venous leg ulcers
2. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous leg ulcers
3. Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases. Implications for venous ulcer formation
4. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments
5. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants
6. Plasminogen is present in the basal layer of the epidermis
7. Plasminogen activators, integrins, and the coordinated regulations of cell adhesion and migration
8. 2 integrins in vivo
9. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator
10. A proenzyme form of human urokinase
11. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro
12. Type 1 plasminogen activator inhibitor and its potential influence on thrombotic therapy
13. Biological and clinical aspects of plasminogen activator inhibitor type-2
14. Tissue and urokinase plasminogen activators in the environs of venous and ischaemic leg ulcers
15. Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo
16. Pattern of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds
17. Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors
18. Blood and veinwall fibrinolytic activity in health and vascular disease
19. The fibrinolytic activity of varicose veins
20. Proceedings: Fibrinolysis and fat necrosis in the lower leg
21. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway
22. Extravasation of macromolecules and possible trapping of transforming growth factor-β in venous leg ulcers
23. Growth factors in the regulation of pericellular proteolysis: A review
24. TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells